Election 2014
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

14th-Feb-2013 13:43Source: BSE

Dr Reddys Labs - Announces Q3 results, Results Press Release & Limited Review Report for the Quarter ended December 31, 2012

Dr Reddys Laboratories Ltd has announced the following results for the quarter ended December 31, 2012:

The Unaudited results for the Quarter ended December 31, 2012

The Company has posted a net profit of Rs. 3466.40 million for the quarter ended December 31, 2012 as compared to Rs. 1080.30 million for the quarter ended December 31, 2011. Total Income has increased from Rs. 16318.60 million for the quarter ended December 31, 2011 to Rs. 21863.00 million for the quarter ended December 31, 2012.

The Consolidated Results are as follows:

The Unaudited results for the Quarter ended December 31, 2012

The Group has posted a net profit of Rs. 3633.10 million for the quarter ended December 31, 2012 as compared to Rs. 5129.60 million for the quarter ended December 31, 2011. Total Income has increased from Rs. 27856.70 million for the quarter ended December 31, 2011 to Rs. 28884.70 million for the quarter ended December 31, 2012.

Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2014-05-13

Audited Results & Dividend

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(April 15, 2014)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
3150

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1890

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1890

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.